Med-O-Meter

5

MedHead Message:

This just goes to show the outrageousness of our existing healthcare system. I’m all for new medications if they have been shown to significantly improve health and reduce mortality over older medications, not who can produce significantly flashier TV ads or glossy magazine inserts.

References:

1. Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study Diabet Med. 2012 Oct;29(10):1260-7 2. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial Am J Med. 1997 Dec;103(6):491-7 3. https://www.goodrx.com/trulicity 4. https://www.goodrx.com/metformin?drug-name=metformin